Approval · Notice of Compliance 38146 · 2026
HALOPERIDOL INJECTION: Notice of Compliance 38146
Issued August 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38146
- Date
- August 20, 2026
- Company
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Merger/Buy-out
- Canadian reference product
- HALOPERIDOL INJECTION USP (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION | 02366010 | Marketed |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML